Price Alert

Sartorius Stedim Biotech ... (SDMHF)

PNK: SDMHF · Real-Time Price · USD

216.65

-3.35 (-1.52%)

At close: May 30, 2025, 3:33 PM

Sartorius Stedim Biotech S.A. Income Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	744.6M	751.3M	655.4M	706.4M	666.9M	706.8M	666.9M	675.7M	726.1M	890M	878.4M	861.8M	862.5M	778.18M	757M	696.7M	655.2M
Cost of Revenue	388.3M	435M	380M	400.1M	358.5M	453.6M	386M	350.8M	351.6M	416.9M	417.4M	415.9M	408M	370.87M	347.1M	312.4M	303.4M
Gross Profit	356.3M	316.3M	275.4M	306.3M	308.4M	253.2M	280.9M	324.9M	374.5M	473.1M	461M	445.9M	454.5M	407.3M	409.9M	384.3M	351.8M
Operating Income	141.3M	109.6M	70.8M	112.8M	113.2M	45.6M	76.9M	185.7M	169M	216.2M	289.5M	294.5M	348.8M	-2.38M	233.7M	219.8M	206.2M
Interest Income	37.5M	-21.4M	2.6M	12.8M	33.1M	17M	n/a	72.9M	15.3M	n/a	35.1M	37.2M	87.5M	n/a	3.9M	2.9M	8.7M
Pretax Income	115.4M	40.9M	35.5M	65.4M	77M	58.1M	35.5M	158.9M	148.6M	235.9M	273.5M	283.2M	337.8M	63.82M	209.5M	202.8M	170.9M
Net Income	85.6M	45.6M	25.5M	47.6M	56M	39.8M	25.7M	133.1M	111.1M	186.7M	200.6M	214.8M	270.2M	8.21M	148.8M	148.5M	125.8M
Selling & General & Admin	166.5M	174M	155.7M	158.3M	160.7M	170.6M	149.7M	143.2M	152.8M	152.3M	154.6M	143.6M	150.6M	155.56M	126.9M	130.6M	118.7M
Research & Development	39.2M	37.1M	37.3M	35.2M	34.5M	37M	28.4M	28.8M	35.4M	38.5M	28.9M	31.7M	33.3M	31.19M	27.1M	27.6M	24.7M
Other Expenses	9.3M	-4.4M	11.7M	35.2M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	215M	206.7M	204.7M	193.5M	195.2M	207.6M	204.1M	212M	220.8M	163.2M	206.6M	188.6M	193.2M	168.22M	180.1M	167.4M	154.3M
Interest Expense	63.3M	11.2M	37.9M	51.7M	n/a	64M	41.4M	26.8M	20.4M	n/a	16M	11.3M	11M	n/a	24.2M	17M	35.3M
Selling & Marketing Expenses	126.8M	121.6M	118.4M	118.9M	121.1M	115.5M	110.2M	108.2M	115.3M	113M	115.7M	108.1M	109.7M	114.65M	101.9M	98.3M	90.8M
Cost & Expenses	603.3M	641.7M	584.7M	593.6M	553.7M	661.2M	590.1M	562.8M	572.4M	580.1M	624M	604.5M	601.2M	539.1M	527.2M	479.8M	457.7M
Income Tax Expense	30M	-5.4M	9.2M	16.8M	20M	16.9M	9.2M	25.8M	37.1M	46.2M	68.5M	68.5M	67.4M	56.91M	63.1M	58.3M	54.1M
Shares Outstanding (Basic)	97.27M	97.32M	97.32M	97.32M	96.72M	92.16M	92.17M	92.17M	92.17M	92.17M	92.02M	92.18M	92.18M	92.18M	92.18M	92.18M	92.5M
Shares Outstanding (Diluted)	97.27M	97.32M	97.32M	97.32M	96.72M	92.16M	92.17M	92.17M	92.17M	92.17M	92.12M	92.19M	92.22M	92.18M	92.42M	92.24M	92.5M
EPS (Basic)	0.88	0.47	0.26	0.49	0.58	0.43	0.28	1.44	1.21	2.03	2.18	2.33	2.93	0.09	1.61	1.61	1.36
EPS (Diluted)	0.88	0.47	0.26	0.49	0.58	0.43	0.28	1.44	1.21	2.03	2.18	2.33	2.93	0.09	1.61	1.61	1.36
EBITDA	256.1M	132.7M	149.6M	178.9M	183.6M	159.7M	152.9M	163.3M	217.6M	272.3M	331.7M	300M	389.5M	33.47M	269.2M	253.5M	238.6M
EBIT	178.7M	52.1M	73.4M	117.1M	110M	97.2M	76.8M	185.7M	169M	216.2M	290.6M	257.3M	261.3M	-2.38M	229.8M	220.9M	207M
Depreciation & Amortization	77.4M	80.6M	76.2M	74.5M	70.4M	62.5M	76.1M	50.4M	48.6M	56.1M	42.2M	42.7M	40.7M	35.86M	39.4M	33.9M	31.5M